Form 4: Pacira BioSciences Officer Jonathan Slonin Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, reports the disposal of 1,615 shares to cover tax obligations upon vesting of a restricted stock unit award.
Summary
- On June 3, 2024, Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, disposed of 1,615 shares of common stock to cover tax withholding obligations.
- The shares were withheld by the issuer at a price of $30.89 per share.
- Following the transaction, Slonin beneficially owns 49,581.475 shares of Pacira BioSciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company officers and directors. This transaction is a common occurrence related to the vesting of stock awards and the associated tax liabilities.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of transaction (stock disposal for tax withholding) |
| 06/05/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.